15.86
price down icon3.06%   -0.50
after-market Dopo l'orario di chiusura: 16.04 0.18 +1.13%
loading

Benitec Biopharma Inc Borsa (BNTC) Ultime notizie

pulisher
09:04 AM

Benitec Biopharma appoints former Intra-Cellular CEO to board - Investing.com

09:04 AM
pulisher
12:14 PM

Benitec Biopharma appoints former Intra-Cellular CEO to board By Investing.com - Investing.com South Africa

12:14 PM
pulisher
09:57 AM

Benitec Biopharma Shares Surge 20% After FDA Grants Fast Track Status for OPMD Gene Therapy - MSN

09:57 AM
pulisher
09:35 AM

Is Benitec Biopharma Inc. a candidate for recovery playMarket Sentiment Summary & Accurate Buy Signal Alerts - newser.com

09:35 AM
pulisher
09:31 AM

Is Benitec Biopharma Inc. stock positioned well for digital economyTrade Analysis Summary & Safe Swing Trade Setups - newser.com

09:31 AM
pulisher
08:58 AM

Custom strategy builders for tracking Benitec Biopharma Inc.Weekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

08:58 AM
pulisher
08:22 AM

Pattern recognition hints at Benitec Biopharma Inc. upside2025 Winners & Losers & Long-Term Growth Plans - newser.com

08:22 AM
pulisher
08:02 AM

Is Benitec Biopharma Inc. stock affected by interest rate hikesFed Meeting & Low Drawdown Trading Techniques - newser.com

08:02 AM
pulisher
07:37 AM

Benitec Biopharma (BNTC) Announces Promising Phase 1b/2a Trial R - GuruFocus

07:37 AM
pulisher
07:32 AM

Benitec Biopharma’s BB-301 Receives FDA Fast Track - TipRanks

07:32 AM
pulisher
07:25 AM

Benitec Biopharma stock soars after FDA Fast Track designation for OPMD drug By Investing.com - Investing.com Nigeria

07:25 AM
pulisher
07:23 AM

Benitec Biopharma stock soars after FDA Fast Track designation for OPMD drug - Investing.com Canada

07:23 AM
pulisher
07:15 AM

Benitec Biopharma Appoints Dr. Sharon Mates to Board of Directors - TradingView

07:15 AM
pulisher
07:10 AM

Benitec Biopharma Provides Positive Interim Clinical Study - GlobeNewswire

07:10 AM
pulisher
07:01 AM

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy - GlobeNewswire

07:01 AM
pulisher
07:00 AM

Benitec Biopharma (NASDAQ: BNTC) appoints Sharon Mates; led ITI to $14.6B J&J deal - Stock Titan

07:00 AM
pulisher
06:59 AM

Can Benitec Biopharma Inc. rally from current levels2025 Momentum Check & Free Community Supported Trade Ideas - newser.com

06:59 AM
pulisher
06:30 AM

Strategies to average down on Benitec Biopharma Inc.July 2025 PreEarnings & Accurate Intraday Trade Tips - newser.com

06:30 AM
pulisher
06:16 AM

Can Benitec Biopharma Inc. stock beat analyst upgradesJuly 2025 Action & Momentum Based Trading Ideas - newser.com

06:16 AM
pulisher
04:40 AM

Is Benitec Biopharma Inc. stock attractive for growth ETFsProfit Target & Technical Pattern Based Signals - newser.com

04:40 AM
pulisher
04:32 AM

What sentiment indicators say about Benitec Biopharma Inc. stock2025 Trading Recap & Daily Growth Stock Investment Tips - newser.com

04:32 AM
pulisher
03:52 AM

Using economic indicators to assess Benitec Biopharma Inc. potentialShare Buyback & Capital Protection Trading Alerts - newser.com

03:52 AM
pulisher
02:51 AM

Benitec Biopharma Inc. recovery potential after sell off2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com

02:51 AM
pulisher
Nov 02, 2025

Full Stock Market News from 2025-11-02 - Stock Titan

Nov 02, 2025
pulisher
Nov 02, 2025

Benitec Biopharma (NASDAQ: BNTC) to Share BB-301 OPMD Study Update in Investor Webcast - Stock Titan

Nov 02, 2025
pulisher
Nov 02, 2025

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy - GlobeNewswire Inc.

Nov 02, 2025
pulisher
Nov 02, 2025

Benitec Biopharma Inc. stock trendline breakdownJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Chart based analysis of Benitec Biopharma Inc. trends2025 Institutional Moves & AI Powered Market Trend Analysis - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Benitec Biopharma Inc. stock attractive for long term wealth buildingJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Will HYGH stock return to pre crash levels2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Real time social sentiment graph for Benitec Biopharma Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 28, 2025

Why Benitec Biopharma Inc. stock is popular among millennials2025 Top Gainers & Precise Entry and Exit Recommendations - fcp.pa.gov.br

Oct 28, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):